Core Viewpoint - Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd. has completed the registration of business changes and has received a new business license, reflecting its updated operational scope and corporate governance [1][2][3] Company Information - The company held its 12th meeting of the 4th Board of Directors on March 6, 2025, and the first extraordinary general meeting of shareholders on March 24, 2025, to approve the changes in business scope and amendments to the Articles of Association [1] - The new business license was issued by the Changsha Market Supervision Administration, confirming the company's name, registration capital of 205.432 million yuan, and legal representative Wang Yiqing [1][2] Business Scope - The company’s operational scope includes a wide range of activities such as drug import and export, retail and wholesale of drugs, medical device sales and rentals, food sales, and various health services [1][2] - Specific licensed projects include the sale of medical masks, food sales (only pre-packaged), and internet information services related to medical devices [1][2] - General projects encompass a variety of services and products, including health consulting, cosmetics retail, and agricultural product sales, among others [2]
湖南达嘉维康医药产业股份有限公司关于完成工商变更登记并换发营业执照的公告